Lincoln National Corp’s Outlook Therapeutics OTLK Stock Holding History

Lincoln National Corp’s Portfolio OTLK Stock Details OTLK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,165	Closed	-$24.9K	–	1228
2023 Q4	$24.9K	Sell	3,165 -12,850	-80%	-$109K	﹤0.01%	1094
2023 Q3	$70.8K	Hold	16,015	–	–	﹤0.01%	1004
2023 Q2	$557K	Buy	16,015 +6,300	+65%	+$172K	0.01%	562
2023 Q1	$212K	Hold	9,715	–	–	﹤0.01%	910
2022 Q4	$210K	Buy	9,715 +2,050	+27%	+$44.6K	﹤0.01%	857
2022 Q3	$187K	Hold	7,665	–	–	﹤0.01%	820
2022 Q2	$156K	Buy	7,665 +2,500	+48%	+$71.9K	﹤0.01%	819
2022 Q1	$184K	Hold	5,165	–	–	﹤0.01%	872
2021 Q4	$140K	Sell	5,165 -7,500	-59%	-$268K	﹤0.01%	862
2021 Q3	$550K	Hold	12,665	–	–	0.01%	474
2021 Q2	$631K	Buy	+12,665	New	+$588K	0.01%	427

Other funds holding OTLK

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $244M AUM 80.12% 1-Year Est. Return

Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return